John G. Catalano

538 total citations
17 papers, 413 citations indexed

About

John G. Catalano is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, John G. Catalano has authored 17 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in John G. Catalano's work include Bone Metabolism and Diseases (8 papers), Natural product bioactivities and synthesis (8 papers) and Biochemical and Structural Characterization (5 papers). John G. Catalano is often cited by papers focused on Bone Metabolism and Diseases (8 papers), Natural product bioactivities and synthesis (8 papers) and Biochemical and Structural Characterization (5 papers). John G. Catalano collaborates with scholars based in United States. John G. Catalano's co-authors include Andrew Spaltenstein, Kristjan S. Gudmundsson, Michael M. Thomson, Sharon Boggs, Lois L. Wright, Larry R. Miller, David N. Deaton, Stephen Jenkinson, Pat Wheelan and Robert B. McFadyen and has published in prestigious journals such as Molecular Pharmacology, Tetrahedron Letters and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

John G. Catalano

17 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John G. Catalano United States	12	236	175	81	48	34	17	413
Andrei W. Konradi United States	14	298 1.3×	328 1.9×	63 0.8×	20 0.4×	25 0.7×	27	754
Carolyn A. Weigelt United States	14	255 1.1×	147 0.8×	169 2.1×	26 0.5×	53 1.6×	25	520
John J. Court United States	13	151 0.6×	298 1.7×	46 0.6×	18 0.4×	11 0.3×	20	430
Scot Campbell United States	15	256 1.1×	412 2.4×	155 1.9×	34 0.7×	21 0.6×	28	648
Damian O. Arnaiz United States	13	283 1.2×	345 2.0×	42 0.5×	36 0.8×	58 1.7×	18	617
Elizabeth A. Malloy United States	9	155 0.7×	189 1.1×	69 0.9×	22 0.5×	51 1.5×	10	370
Marc Lang Switzerland	12	307 1.3×	225 1.3×	156 1.9×	22 0.5×	18 0.5×	26	544
Masahiro Ikejiri Japan	11	182 0.8×	246 1.4×	111 1.4×	146 3.0×	9 0.3×	24	521
Michael R. Michaelides United States	14	580 2.5×	298 1.7×	141 1.7×	45 0.9×	13 0.4×	15	751
William A. Metz United States	13	172 0.7×	262 1.5×	53 0.7×	39 0.8×	30 0.9×	22	424

Countries citing papers authored by John G. Catalano

Since Specialization

Citations

This map shows the geographic impact of John G. Catalano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Catalano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Catalano more than expected).

Fields of papers citing papers by John G. Catalano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John G. Catalano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Catalano. The network helps show where John G. Catalano may publish in the future.

Co-authorship network of co-authors of John G. Catalano

This figure shows the co-authorship network connecting the top 25 collaborators of John G. Catalano. A scholar is included among the top collaborators of John G. Catalano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John G. Catalano. John G. Catalano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Catalano, John G., et al.. (2015). Phenoxide leaving group SNAr strategy for the facile preparation of 7-amino-3-aryl pyrazolo[1,5-a]pyrimidines from a 3-bromo-7-phenoxypyrazolo[1,5-a]pyrimidine intermediate. Tetrahedron Letters. 56(44). 6077–6079. 6 indexed citations

Catalano, John G., Kristjan S. Gudmundsson, Sharon Boggs, et al.. (2010). Synthesis of a novel tricyclic 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system and CXCR4 antagonists with potent activity against HIV-1. Bioorganic & Medicinal Chemistry Letters. 20(7). 2186–2190. 34 indexed citations

Gudmundsson, Kristjan S., Paul R. Sebahar, John F. Miller, et al.. (2009). Amine substituted N-(1H-benzimidazol-2ylmethyl)-5,6,7,8-tetrahydro-8-quinolinamines as CXCR4 antagonists with potent activity against HIV-1. Bioorganic & Medicinal Chemistry Letters. 19(17). 5048–5052. 44 indexed citations

Gudmundsson, Kristjan S., Paul R. Sebahar, John G. Catalano, et al.. (2009). Substituted tetrahydrocarbazoles with potent activity against human papillomaviruses. Bioorganic & Medicinal Chemistry Letters. 19(13). 3489–3492. 42 indexed citations

Gudmundsson, Kristjan S., Sharon Boggs, John G. Catalano, et al.. (2009). Imidazopyridine-5,6,7,8-tetrahydro-8-quinolinamine derivatives with potent activity against HIV-1. Bioorganic & Medicinal Chemistry Letters. 19(22). 6399–6403. 74 indexed citations

Barrett, David G., John G. Catalano, David N. Deaton, et al.. (2006). Novel, potent P2–P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(6). 1735–1739. 16 indexed citations

Barrett, David G., John G. Catalano, David N. Deaton, et al.. (2006). Acyclic, orally bioavailable ketone-based cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(1). 22–27. 6 indexed citations

Barrett, David G., John G. Catalano, David N. Deaton, et al.. (2005). A structural screening approach to ketoamide-based inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 15(9). 2209–2213. 12 indexed citations

Barrett, David G., John G. Catalano, David N. Deaton, et al.. (2005). P2–P3 conformationally constrained ketoamide-based inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 15(15). 3540–3546. 27 indexed citations

10.

Catalano, John G., David N. Deaton, Eric S. Furfine, et al.. (2004). アルデヒド系カテプシンK阻害剤のP 1 部位SAR探究. Bioorganic & Medicinal Chemistry Letters. 14(1). 275–278. 26 indexed citations

11.

Barrett, David G., John G. Catalano, David N. Deaton, et al.. (2004). Potent and selective P2–P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1′, P1, and/or P3 substitutions. Bioorganic & Medicinal Chemistry Letters. 14(19). 4897–4902. 24 indexed citations

12.

Barrett, David G., John G. Catalano, David N. Deaton, et al.. (2004). Orally bioavailable small molecule ketoamide-based inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 14(10). 2543–2546. 10 indexed citations

13.

Catalano, John G., David N. Deaton, Stacey T. Long, et al.. (2004). Design of Small Molecule Ketoamide‐Based Inhibitors of Cathepsin K.. ChemInform. 35(23). 1 indexed citations

14.

Catalano, John G., David N. Deaton, Stacey T. Long, et al.. (2003). Design of small molecule ketoamide-based inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 14(3). 719–722. 19 indexed citations

15.

Catalano, John G., David N. Deaton, Eric S. Furfine, et al.. (2003). Exploration of the P1 SAR of aldehyde cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(1). 275–278. 32 indexed citations

16.

Lynch, Kevin R., et al.. (1997). Structure/Activity Relationships in Lysophosphatidic Acid: The 2-Hydroxyl Moiety. Molecular Pharmacology. 52(1). 75–81. 30 indexed citations

17.

Hopper, Darrin W., John G. Catalano, & Timothy L. Macdonald. (1996). Facile synthesis of lysophospholipids containing unsaturated fatty acid chains. Tetrahedron Letters. 37(44). 7871–7874. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact